Met Life Investment Management, LLC Cabaletta Bio, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 27,714 shares of CABA stock, worth $59,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,714
Previous 27,714
-0.0%
Holding current value
$59,585
Previous $207,000
37.2%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CABA
# of Institutions
126Shares Held
47.9MCall Options Held
202KPut Options Held
110K-
Jennison Associates LLC5.63MShares$12.1 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$10.2 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY4.12MShares$8.86 Million0.1% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.67MShares$7.9 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$6.53 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $62.4M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...